Home - Products - GPCR/G Protein - cAMP - Adenosine receptor A1 antagonist 5

Adenosine receptor A1 antagonist 5

CAS No. 85872-53-3

Adenosine receptor A1 antagonist 5( —— )

Catalog No. M33817 CAS No. 85872-53-3

Adenosine receptor A1 antagonist 5 acts as an adenosine antagonist, is an oxypurine, acts as an insecticide and pest control agent, and has an inhibitory effect on elevated blood pressure.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 149 Get Quote
5MG 228 Get Quote
10MG 333 Get Quote
25MG 552 Get Quote
50MG 787 Get Quote
100MG 1062 Get Quote
500MG 2124 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Adenosine receptor A1 antagonist 5
  • Note
    Research use only, not for human use.
  • Brief Description
    Adenosine receptor A1 antagonist 5 acts as an adenosine antagonist, is an oxypurine, acts as an insecticide and pest control agent, and has an inhibitory effect on elevated blood pressure.
  • Description
    NPC 200 is a potent and selective antagonist of Adenosine A1 Receptor. NPC 200 reverses NECA-induced left and right atrial depression with EC50s of 1.08 and 2.03 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    cAMP
  • Recptor
    cAMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    85872-53-3
  • Formula Weight
    312.37
  • Molecular Formula
    C17H20N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)N1C2=C(NC(=N2)C3=CC=CC=C3)C(=O)N(CCC)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. P. V. Kaplita, et al. NPC 205 is a potent and selective adenosine A1, receptor antagonist: Correlation among receptor binding, biochemical, and physiological assays. , 20(4), 429–443.
molnova catalog
related products
  • 7-O-Methylrosmanol

    7-O-Methylrosmanol can effectively suppress FSK-induced luciferase expression under the control of the CRE, PEPCK-C and G6Pase gene promoters, it may contribute to its antihyperglycemic activity.

  • ESI-08

    ESI-08 is an effective antagonist of EPAC2 with an IC50 of 8.4 μM. ESI-08 selectively blocks cAMP-induced EPAC activation but not cAMP-mediated PKA activation.

  • 0990CL

    0990CL is an effective heterotrimer Gαi subunit specific inhibitor, which can interact with purified Go± in GDP-bound state, and can block α2AR mediated cAMP regulation.